Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-26
1996-10-08
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424122, A61K 3171
Patent
active
055631460
ABSTRACT:
This invention provides a method of preventing or treating hyperproliferative vascular disease in a mammal by administering an antiproliferative effective amount of rapamycin alone or in combination with mycophenolic acid.
REFERENCES:
patent: 3929992 (1975-12-01), Sehgal et al.
patent: 4885171 (1989-12-01), Surendra et al.
patent: 5078999 (1992-01-01), Warner et al.
patent: 5080899 (1992-01-01), Sturm et al.
patent: 5100899 (1992-03-01), Calne
patent: 5252579 (1993-10-01), Skotnicki
patent: 5256790 (1993-10-01), Nelson
patent: 5288711 (1994-02-01), Mitchell
Gregory C. R., et al., American Society of Transplant Physicians, 13th Annual Meeting, May 16-18, 1994; Abstract (38) 9, mailed to attendees Apr. 27, 1994.
Gregory C. R., et al., American Society of Transplant Physicians, 13th Annual Meeting, May 16-18, 1994; Abstract (38) 10, mailed to attendees Apr. 27, 1994.
Gregory C. R., et al., Transplantation Proceedings, 25:1, 120-121 (Feb. 1993).
Gregory C. R., et al., Transplantation Proceedings, 25:1, 770-771 (Feb. 1993).
Gregory C. R., et al., Transplantation, 55:1409-1418 (Jun. 1993).
Gregory C. R., et al., Veterinary Surgery, Abstract 11:40 (Jan. 1993).
Gregory C. R. et al., J. Heart and Lung Transplantation, Abstract 27, 11:197 (1992).
Gregory C. R. et al., FASEB, Abstract 21, 6:A940 (1992).
Meiser, B. M. et al., J. Heart and Lung Transplantation, Abstract 3, 9:55 (1990).
Meiser, B. M. et al., Lancet 338:1297-1298 (1991).
Ferns, G. A. et al., Circulation, Abstract 0727, 80 (Supp. II) 183 (1989).
Jonasson, L. et al., Proc. Natl. Acad. Sci., 85:2303-2306 (Apr. 1988).
Morris, P. J. et al., Transplantation Reviews, 6:39 (1992).
Staruch, M. J., FASEB 3:3411 (1989).
Martel, R. R., Canadian Journal of Physiol. Pharmacology, 55:48 (1977).
Morris, R. E., Med. Sci. Res. 17:877 (1989).
Baeder, W. L., Fifth Int. Conf. Inflamm. Res. Assoc. 121 (Abstract) (1990).
Eng, C. P. et al., The Journal of Antiboitics, 37:1231 (1984).
The Merck Index, 9th ed., 6152:829-821 (1976).
Weaver, J. L., J. Cell Biology, Abstract 1308, 111:(5 Part 2)234a.
Transplantation Proc. 23:2833 (1991).
Cytokine 3:472 (1991).
Transplantation Proc. 23:507 (1991).
Transplantation 50:554 (1990).
Immunology 72:544 (1991).
Ferns, G., Am. J. Path. 137:403 (1990).
Transplantation Proc. 23:2833 (1991).
Gregory Clare R.
Morris Randall E.
American Home Products Corporation
Milowsky Arnold S.
Wityshyn Michael G.
Witz Jean C.
LandOfFree
Method of treating hyperproliferative vascular disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating hyperproliferative vascular disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hyperproliferative vascular disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-57513